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Hydroxylamine acutely activates glucose uptake in L929
fibroblast cells
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Abstract
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Nitroxyl (HNO) has a unique, but varied, set of biological properties including beneficial effects
on cardiac contractility and stimulation of glucose uptake by GLUT1. These biological effects are
largely initiated by HNO’s reaction with cysteine residues of key proteins. The intracellular
production of HNO has not yet been demonstrated, but the small molecule, hydroxylamine (HA),
has been suggested as possible intracellular source. We examined the effects of this molecule on
glucose uptake in L929 fibroblast cells. HA activates glucose uptake from 2 to 5-fold within two
minutes. Prior treatment with thiol active compounds, such as iodoacetamide (IA),
cinnamaldehyde (CA), or phenylarsine oxide (PAO) blocks HA activation of glucose uptake.
Incubation of HA with the peroxidase inhibitor, sodium azide, also blocks the stimulatory effects
of HA. This suggests that HA is oxidized to HNO by L929 fibroblast cells, which then reacts with
cysteine residues to exert its stimulatory effects. The data suggest that GLUT1 is acutely activated
in L929 cells by modification of cysteine residues, possibly the formation of a disulfide bond
within GLUT1 itself.
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1. Introduction
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There is increasing interest in the unique biological effects of nitroxyl (HNO), effects that
can be distinguished from the effects of nitric oxide (NO) [1-7]. HNO reacts with several
cardiac sarcoplasmic proteins involved in calcium release and uptake, and thereby, enhances
cardiac contractility [8-11]. The observation that HNO also inhibits aldehyde dehydrogenase
makes it an effective treatment for alcoholism [12, 13]. Many of the biological effects of
HNO have been attributed to its propensity to react with cysteine residues. HNO can add to
a single cysteine residue to form a N-hydroxysulfenamide, which can rearrange to produce a
sulfinamide, or react with second cysteine residue to generate a disulfide bond [3]. The
reaction of HNO with thiols accounts for its inhibitory effects on, glyceraldehyde-3phosphate dehydrogenase [14, 15] and cysteine proteases such as papain [16] and cathepsin
B [17]. More recently, we have shown that HNO rapidly activates GLUT1 in L929
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fibroblast cells and this effect can be block prior treatment with thiol-reactive reagents, such
as iodoacetamide and cinnamaldehyde [18].
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There is an increasing list of reagents or cellular conditions, including azide [19, 20],
methylene blue [21], osmotic stress [22, 23], C-peptide [24], glucose deprivation [25, 26]
and HNO [18] that acutely activate GLUT1. Acute activation of GLUT1 does not involve a
change in either the expression or the membrane concentration of the transporter [19]. While
the mechanism for the acute activation of GLUT1 is not completely understood, there is
mounting evidence that activation of GLUT1 in L929 fibroblast cells requires modification
of key cysteine residues [18, 27, 28]. The data in these previously cited studies are
consistent with the suggestion that GLUT1 is more active when it assembles into tetramers.
These tetramers appear to be stabilized by the conformational changes that occur within
GLUT1 after the formation of an internal disulfide bond [29-31].
It is not clear if the effects of HNO are simply pharmacological, or if they actually represent
a cellular signaling system [3, 4, 7]. The substrate for the production of HNO is not known
but several small molecules have been suggested, including hydroxylamine (HA) [5, 7, 32,
33]. To explore this further, we investigated the effects of HA on the transport activity of
GLUT1 in L929 fibroblast cells (GLUT1 is the exclusive glucose transporter in this cell line
[34]).
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2. Materials and Methods
2.1 Chemicals
Angeli’s salt (AS) was a generous gift of Dr. John P. Toscano (Johns Hopkins University).
Phenylarsine oxide (PAO), cinnamaldehyde (CA), iodoacetamide (IA), (HA), sodium azide
(Az), 2-deoxy-D-glucose-[1,2-3H] (2DG) and D-mannitol-1-14C were purchased from the
Sigma-Aldrich Chemical Company (St. Louis, MO, USA).
2.2 Cell culture
L929 mouse fibroblast cells were obtained from the American Type Culture Collection. To
initiate each experiment, approximately 1.5 × 105 L929 fibroblast cells were plated into each
well of a 24-well culture-treated plate in 1.0 mL of low glucose (5.5 mM) DMEM
(Dulbecco’s Modified Eagle Medium) supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin. The cells were grown overnight at 37 °C in an incubator supplied
with humidified room air with 5% CO2. Since the magnitude of stimulatory effects varies
somewhat depending on the confluency of the cells, experiments were normally done with
cells near confluency (3.2 × 105 cells/well for a 24-well plate).
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2.3 General experimental design
To initiate an experiment, the media from cells in 24-well plates were removed and then
incubated in 0.4 mL of fresh treatment media consisting of either low-glucose DMEM alone
(0% FBS) (basal) or low-glucose DMEM plus the chemical of interest (see figure legends).
Cells were maintained at 37 °C for the times indicated. In all experiments using AS, the
solid compound was quickly dissolved in media at room temperature immediately
distributed to the cells in the 24-well plate (process took about 30 seconds). All other
reagents were added to the media or 2DG uptake solution from 100-200x aqueous (sodium
azide, IA, HA), or ethanol (CA) or DMSO (PAO) stock solutions. Ethanol and DMSO at the
concentrations added have no effect on glucose uptake [27, 28].

Biochimie. Author manuscript; available in PMC 2014 April 01.

Louters et al.

Page 3

2.4 Glucose uptake assay
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Glucose uptake was measured using the radiolabeled glucose analog 2-deoxyglucose (2DG)
as previously described [35]. Briefly, the media was replaced with 0.2 mL of glucose-free
HEPES buffer (140 mM NaCl, 5 mM KCl, 20 mM HEPES/Na pH=7.4, 2.5 mM MgSO4, 1
mM CaCl2, 2 mM NaPyruvate, 1 mM mannitol) supplemented with 1.0 mM (0.3 μCi/mL)
2-DG (1,2-3H) and 1.0 mM (0.02 μCi/mL) mannitol (1-14C). Uptake media was
supplemented with additional compounds, such as AS or HA, as indicated in the figure
legends. After a 10-minute incubation, cells were washed twice with cold glucose-free
HEPES. The cells were lysed in 0.5 mL lysis buffer (10 mM Tris pH=7.4, 150 mM NaCl, 5
mM EDTA, 1.0% triton X-100, 0.4% SDS) and the 3H-2 DG and 14C-mannitol were
measured using scintillation spectrometry. Mannitol is not normally taken up by cells,
therefore the inclusion of 14C-mannitol in the uptake media is an extracellular marker and it
allows us to account for any surface binding, to monitor potential toxic effects of the
experimental treatments that would compromise the cell membrane, and to account for
excess radioactivity that might remain after the washes.
2.5 Statistical analysis
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Experimental conditions were repeated in triplicate or quadruplicate and glucose uptake was
measured and reported as nmol/10 min/well ±standard error. Statistical significance was
determined by either ANOVA followed by a post-hoc Dunnett test or a two-tailed t-test.
Statistical significance is reported at P< 0.01 or P<0.05. Experiments were repeated several
times and results from representative experiments are reported. Alternatively, several
experiments were combined and normalized to glucose uptake under control conditions.

3. Results
3.1 Hydroxylamine activates glucose uptake in a dose dependent manner

NIH-PA Author Manuscript

HNO, supplied via AS, activates glucose uptake in L929 cells within minutes. However, a
cellular source of HNO has not been identified. It has been suggested that HA can be
oxidized to produce HNO [7]. Therefore, we were interested in determining the effects of
HA on glucose uptake. The dose dependent effects of HA on glucose uptake were measured
by varying the concentration of HA in the uptake media from 0-20 mM, the same effective
concentration range as HNO [18]. As seen in Figure 1, 1.0 mM HA significantly activated
glucose uptake (2.3-fold) and both 5.0 and 10.0 mM HA were maximally stimulating (3.7fold). At 20.0 mM HA glucose uptake was slightly, but significantly reduced from the
maximum effect. This is virtually identical to the results observed for HNO [18]. HA did not
produce any visible toxic effects at any of the concentrations tested, as assessed by cell
morphology and cell attachment.
3.2 Time course of HA-activation and recovery of glucose uptake
HA-activation occurs within the ten-minute time frame required for the measurement of
glucose uptake. To explore this more carefully, glucose uptake was measure in the presence
of 5.0 mM HA for 0, 1.5, 3, 5, 8, 10, 15, or 20 minutes and the subsequent uptakes were
expressed per minute. The zero time exposure to HA was the uptake per minute for a 20minute exposure to the uptake solution without HA present. Previous work has shown that
2DG uptake is linear for 30 minutes even under activating conditions (data not shown). As
seen in Figure 2, the maximum rate of uptake (4.7-fold higher) occurs within the first 1.5
minutes of exposure to HA.
To measure the recovery from the effects of HA, L929 cells were exposed to HA for 10
minutes, followed by incubation in fresh DMEM media (5.5 mM glucose) without HA and
uptakes were measured either immediately or after 5, 25 or 50 minutes. As shown in Figure
Biochimie. Author manuscript; available in PMC 2014 April 01.
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3, about 60% of the activation recovers within 5 minutes, with 40% of the activity
maintained for 25 minutes and dropping to control levels after 50 minutes.
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3.3 Activating effect of HA is blocked by iodoacetamide
Pretreating L929 cells with the thiol-active compound, iodoacetamide (IA) blocked the
activating effects of AS (HNO) [18]. We were curious to determine if IA could also block
the effects of HA. L929 cells were exposed to 0.75 mM IA for 20 minutes and glucose
uptake was measured in the presence and absence of HA. As seen in Figure 4, IA treatment
alone had no effect on glucose uptake, but it completely blocked the activating effects of
HA, suggesting HA is exerting its effects via an interaction with cysteine residues.
3.4 Cinnamaldehye and phenylarsine oxide also block the activating effects of HA
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Both cinnamaldehyde (CA) and phenylarsine oxide (PAO) react with thiols and have been
shown to be acute activators of glucose uptake in L929 cells [27, 28]. We would predict that
if HA is exerting its effects via a reaction with a thiol, the prior treatment and activation by
CA and PAO should block additional activation by HA. L929 cells were treated with either
2.0 mM CA or 50.0 μM PAO for 30 minutes and glucose uptakes were measured in the
presence and absence of 5.0 mM HA. As seen in the Figure 5 and previously reported [27,
28], both CA and PAO acutely activated glucose uptake (2.3 and 2-7-fold respectively).
However, HA was more effective and in this experiment we observed a robust 5-fold
activation of glucose uptake. Prior treatment and activation of glucose uptake by CA and
PAO blocked a full activation by HA.
3.5 Azide inhibits the activating effects of HA
It has been shown that hydroxylamine can be oxidized to HNO by peroxidases and other
hemeproteins [32]. If the activation of glucose uptake by HA requires its conversion to
HNO, peroxidase inhibitors should block HA’s effects. To test this, glucose uptake was
measured in the presence of both HA and sodium azide, a potent peroxidase inhibitor. The
results are shown in Figure 6. Sodium azide alone activated glucose uptake 1.5-fold, but it
completely blocked the activating effects of HA. Somewhat surprisingly, sodium azide also
blocked the activating effects of AS. The magnitude of the response to HA and AS were
both somewhat lower in this experiment, but they were equal to each other in magnitude.
None of the conditions utilized in this experiment appeared to affect cell viability as
monitored by changes in cell morphology or cell attachment.

Discussion
NIH-PA Author Manuscript

The establishment of nitric oxide (NO) as a cellular signaling molecule has spurred research
into the biological effects of other nitrogen oxide species. As a result, it has now been shown
that nitroxyl (HNO), a one-electron reduced analog of NO, has a unique set of biological
effects that distinguishes it from NO [1-7]. In particular, HNO has been shown to be
efficacious in the treatment of alcoholism [12] and has been suggested as a possible
therapeutic agent for the treatment of heart failure [36]. Much of the biological effects of
HNO have been ascribed to its reaction with the thiol side chains of cysteine residues. The
nucleophilic addition of a thiol to HNO produces N-hydroxysulfenamide, which can either
rearrange to form a sulfinamide or react with a second vicinal cysteine residue to produce a
disulfide and release hydroxylamine [2, 3].
Recently it has been shown that HNO, supplied by the decomposition of AS, acutely
activates the glucose uptake activity of GLUT1 [18]. The activating effects of HNO were
blocked by either the prior incubation of AS with thiols or a prior treatment of the cells with
thiol reactive compounds, such as iodoacetamide or cinnamaldehyde. The data supported a
Biochimie. Author manuscript; available in PMC 2014 April 01.
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mechanism of GLUT1 activation that was initially suggested by Curruthers based on his
work on the GLUT1 protein from erythrocytes. Curruthers demonstrated that the formation
of a disulfide bond between Cys 347 and Cys 421 within GLUT1 stabilizes a GLUT1
tetramer, which was a more active form of the transporter [29-31]. They also demonstrated
that iodoacetamide can react with Cys 421. In addition, studies on phospholamban, as well
as computatational studies, suggest that HNO can partition to hydrophobic regions where
formation of a disulfide bond is the preferred product [3, 37, 38]. This strengthens the
suggestion that HNO can react with the membrane bound GLUT1 to form a disulfide bond.
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In order to establish HNO as a distinct cellular signaling system, research needs to identify
an endogenous source of HNO and provide clarity on how specificity is achieved [2, 3]. HA
has been suggested as possible small molecule precursor to HNO [7, 32, 33]. In particular, it
has been demonstrated that HA can be oxidize by horseradish peroxidase and a number of
other hemeproteins to produce HNO [32]. The data presented here indicate that HA activates
glucose uptake in a manner that is virtually identical to the action of HNO, as administered
via AS [18]. The most straightforward explanation of the data presented in this study is that
HA is oxidized to HNO by a cellular enzyme, which then exerts its effects via HNO’s action
on cysteine residues. This conclusion is based on five observations. First, both AS and HA
have nearly identical maximum effects at 5.0 mM (Figure 1, and [18], and Figure 6).
Second, both reagents have an initial burst of activation (1-2 minutes) followed by a
reduction in glucose uptake to a steady state value (Figures 2 and [18]). Third, the activating
effects of both reagents show a similar biphasic recovery with about 60% of the activity lost
in the first 5-10 minutes (Figure 3 and [18]). Fourth, the actions of both compounds are
blocked by prior treatment of the cells with iodoacetamide, which reacts with free thiols
(Figure 4 and [18]) or by pretreatment with the thiol active compounds, CA and PAO, which
themselves are activating (Figure 5 and [18]). And finally, sodium azide, a known inhibitor
of peroxidases and hemeproteins, completely blocks both AS-induced and HA-induced
activation of glucose uptake (see Figure 6). This is consistent with HA being converted to
HNO by an enzyme present in L929 fibroblast cells. While these data are consistent with the
oxidation of HA to HNO, this needs to be confirmed by the direct detection of HNO.
However, these experiments are very difficult due to the reactivity of HNO and its tendency
to dimerize, and then dehydrate to nitrous oxide. There are detection assays that that involve
chemically trapping HNO, but these techniques have not been fully tested in whole cell
experiments [39].
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The small 1.5-fold stimulation of glucose uptake by exposure to azide during the 10-minute
measurement of glucose uptake (Figure 6) is in line with previous studies that investigated
the effects of azide as a cellular respiration inhibitor. Exposure of a variety of cells to azide
for 20-30 minutes activates glucose uptake 3- to 5-fold [18-20]. Interestingly in this study,
while azide alone is slightly activating, it completely inhibits the effects of HA suggesting
that azide is also inhibiting an enzyme responsible for the oxidation of HA to HNO. We did
not initially expect that azide would also inhibit the effects of AS since this compound
releases HNO directly. In fact, data from a previous study had indicated that exposure of
cells to azide activated glucose uptake and the subsequent exposure to AS further activated
uptake [18]. However, in that study the exposure to azide and AS was sequential. The
inhibitory effects of azide reported in this study occurs when the cells are exposed
simultaneously to azide and AS. The inhibition of AS activation suggests that HNO may not
reacting directly with GLUT1 (or a protein responsible for activating GLUT1), but rather it
may be oxidizing any available vicinal thiols to release HA, which can then be reoxidized to
HNO. The eventual modification of GLUT1 may be dependent on this HNO-HA redox
cycling. This HNO-HA redox cycle has been suggested as a possible signaling mechanism
[7]. The millimolar concentration of HA required to activate glucose uptake is significantly
higher than the expected intracellular concentration of HA and higher than the micromolar
Biochimie. Author manuscript; available in PMC 2014 April 01.
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concentrations required for other reported physiological effects of HA [40]. However, it is
reasonable to expect that an exogenous source of HA or AS would not be able to target
specific proteins, especially in a cellular environment that has high concentrations of
proteins and thiols. Therefore, these results also do not preclude the possibility that cells
could target specific proteins by a local or focused production of HNO from HA within the
cell.
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We are suggesting that the activating effects of HA are mediated by its oxidation to HNO,
which then reacts with key cysteine residues, likely within GLUT1 itself, to generate a more
active form of the transporter. However, there are a couple of other possibilities to consider.
First, it is known that HNO alters calcium uptake and release in cardiac cells [8, 9] and that
calcium can alter glucose uptake rates [41, 42]. However, it seems unlikely that calcium is
involved in this HA-effect since previous work has shown that neither altering calcium
concentrations in the media nor treatment with the calcium channel blocker, dantrolene,
alters glucose uptake in L929 cells [43]. Second, there are plausible pathways for the
conversion of HA to NO [7] and it has been previously shown that sodium nitroprusside, a
NO donor, acutely activates glucose uptake [43]. This mechanism also seems unlikely since
the NO effect required a much longer activation time (30-45 minutes compared to 1.5
minutes), and its effect was only about half the effect of HA. However, future experiments
should confirm this by investigating the effects of HA in the presence of either a NO
scavenger and/or an inhibitor of guanylyl cyclase.

5. Conclusions
HA acutely activates the transport activity of GLUT1 in L929 fibroblast cells in a manner
that is nearly identical to the effects of HNO. The data suggest that HA can be converted to
HNO, which activates glucose uptake by its reactions with cysteine residues. Results are
consistent with a proposed mechanism for GLUT1 activation that involves the formation of
a disulfide bond within GLUT1, or reaction with a yet not known protein that regulates
GLUT1 activity.
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•

Hydroxylamine activates glucose uptake in L929 fibroblast cells within minutes

•

Actions of hydroxylamine are virtually identical to actions of nitroxyl

•

Activation by hydroxylamine is block by thiol reactive compounds

•

Azide, a peroxidase inhibitor, blocks activating effects of hydroxylamine
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Figure 1.
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Dose dependent effects of HA on 2DG uptake. Ten-minute 2DG uptakes were measured in
the presence of HA concentrations ranging from 0-20 mM. Data are means ± S.E. of four
wells from a representative experiment. aSignificantly different than 0 mM exposure to AS
at P<0.01 and bsignificantly different than maximum effect at 5.0 mM HA at P<0.05.
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Figure 2.
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Time course for AS-activation of 2DG uptake. 2DG uptakes in the presence of 5.0 mM AS
were measured for 2, 3, 5, 8, 10, 15, and 20 minutes and expressed as the average nmol
2DG/minute ± S.E from four wells of a representative experiment. The uptake at zero
minutes exposed to AS represents the per-minute uptake for a 20-minute uptake for cells not
exposed to HA. aSignificantly different than zero time exposure to AS and bsignificantly
different than maximum effect at 1.5 minute exposure to HA at P<0.01.
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Figure 3.

Effect of recovery time on HA-activated 2DG uptake. L929 fibroblast cells were incubated
at 37 °C for 10 minutes in DMEM media (5.5 mM glucose) supplemented with 5.0 mM HA.
Ten-minute 2DG uptakes were then measured immediately or media were replaced with
HA-free media and uptakes were measured after 5, 25, or 50 minutes. Data are expressed as
a percentage of full activation (0 minutes recovery) ± S.E. from four wells of a
representative experiment. aSignificantly different than basal uptake (0% activation)
and bsignificantly different than 100% activation at P<0.01.
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Figure 4.

Effect of iodoacetamide on HA-activated 2DG uptake. L929 fibroblast cells were treated for
20 minutes at 37 °C in DMEM media (5.5 mM glucose) alone or supplemented with 0.75
mM iodoacetamide. Ten-minute 2DG uptakes were then measured in the presence and
absence of 5 mM HA. (Con) represent control cells not treated with iodoacetamide or HA,
(IA) represent cells exposed to iodoacetamide during the 20-minute treatment, (HA)
represent cells exposed to hydroxylamine during the 10-minute uptake, (IA+HA) represent
cells pre-treated with iodoacetamide and exposed to HA during the uptake phase. Data are
means ± S.E. from four wells of a representative experiment. *Significantly elevated from
control at P<0.01.
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Figure 5.

Effects of CA and PAO on HA-activated 2DG uptake. L929 fibroblast cells were incubated
at 37 °C for 20 minutes in DMEM media (5.5 mM glucose) alone (Con) or supplemented
with either 2.0 mM cinnamaldehyde (CA) or 50 μM phenylarsine oxide (PAO). Ten-minute
2DG uptakes were then measured in the presence and absence of 5.0 mM hydroxylamine
(HA). Data are expressed as a percentage of full activation (0 minutes recovery) ± S.E. from
three wells of a representative experiment. aSignificantly different than basal uptake control
(Con) and bsignificantly different than HA-activation control (HA) at P<0.01.
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Figure 6.

Effects of Azide on HA- and AS-activated 2DG uptake. 2DG uptakes were measured
without any additions (Con), or with the addition of 5.0 mM sodium azide (Az), 5.0 mM
hydroxylamine (HA), 5.0 mM Angeli’s salt (AS), 5.0 mM HA plus 5.0 mM azide (HA+Az),
or 5.0 mM AS plus 5.0 mM azide (HA+Az). Data from 12-20 samples were normalized to
untreated cells (Con) and are expressed as a fraction of control ± S.E.. *Significantly
different than basal uptake (Con) at P<0.01.
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